A jury in the US state of Missouri has ordered Johnson & Johnson (J&J) to pay $72m (£51m) to the family of a woman who claimed her death was linked to use of the company's Baby Powder talc.
Women who carry an inherited fault in the BRIP1 gene are three times more likely to develop ovarian cancer than those without it, researchers say.
Doctors say there is now "encouraging" evidence that an annual blood test may cut ovarian cancer deaths by a fifth.
Regular blood tests can detect 86% of ovarian cancers before the point at which women normally would be diagnosed, according to a trial that could lead to national screening.
American scientists are attempting to modify the DNA of human egg cells using a new gene-editing technique that could eliminate inherited diseases from subsequent generations of affected families
A jury in the US state of Missouri has ordered Johnson & Johnson (J&J) to pay $72m (£51m) to the family of a woman who claimed her death was linked to use of the company's Baby Powder talc.
Women who carry an inherited fault in the BRIP1 gene are three times more likely to develop ovarian cancer than those without it, researchers say.
Doctors say there is now "encouraging" evidence that an annual blood test may cut ovarian cancer deaths by a fifth.
Regular blood tests can detect 86% of ovarian cancers before the point at which women normally would be diagnosed, according to a trial that could lead to national screening.
American scientists are attempting to modify the DNA of human egg cells using a new gene-editing technique that could eliminate inherited diseases from subsequent generations of affected families
